Braveheart Bio（BRVE.US）股东结构 - 机构持仓、大股东与内部人士｜长桥证券

© 2026 Longbridge｜服务条款隐私政策

股东类型

风投/私募71.60%
个人与内部人士17.63%
上市公司10.77%

主要股东

主要股东最新
股东
Forbion Capital Partners B.V.	34.01%	2,182.60 万	--	+2,182.60 万	2026/08/07
Forbion Capital Partners B.V.	34.01%	2,182.60 万	30.40%	+2,072.33 万	2026/08/07
OrbiMed Advisors LLC	18.97%	1,217.52 万	--	+1,217.52 万	2026/08/18
OrbiMed Advisors LLC	18.55%	1,190.18 万	--	+1,190.18 万	2026/08/07
Andreessen Horowitz LLC	15.95%	1,023.24 万	--	+1,023.24 万	2026/08/07
Andreessen Horowitz LLC	15.95%	1,023.24 万	--	+1,023.24 万	2026/08/07
Travis MurdochCEO, President & Director	12.99%	833.36 万	--	+833.36 万	2026/08/07
Travis MurdochCEO, President & Director	12.99%	833.36 万	14.08%	+8.33 万	2026/08/07
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	11.56%	742.01 万	--	+742.01 万	2026/08/07
Jiangsu Hengrui Pharmaceuticals Co.,Ltd	11.56%	742.01 万	--	+742.01 万	2026/08/07
Frazier Life Sciences Management, LP	7.96%	510.74 万	--	+510.74 万	2026/08/07
Jason ColomaFormer Director	1.71%	110.05 万	--	+110.05 万	2026/08/05
Jason ColomaFormer Director	1.71%	110.05 万	1.89%	+0	2026/08/05
David MalekDirector	1.58%	101.33 万	--	+101.33 万	2026/08/07
David MalekDirector	1.58%	101.33 万	1.73%	+4,166.00	2026/08/07
James RickeyChief Financial Officer	1.10%	70.36 万	--	+70.36 万	2026/08/07
James RickeyChief Financial Officer	1.10%	70.36 万	1.12%	+2.78 万	2026/08/07
Christopher ViehbacherIndependent Chairman	0.95%	60.95 万	--	+60.95 万	2026/08/07
Christopher ViehbacherIndependent Chairman	0.95%	60.95 万	1.27%	-6.70 万	2026/08/07
Michele AndersonChief Development Officer	0.52%	33.22 万	--	+33.22 万	2026/08/07